Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 38 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

32%

12 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A

10(34.5%)

Phase 4

7(24.1%)

Phase 3

5(17.2%)

Phase 1

4(13.8%)

Phase 2

2(6.9%)

Early Phase 1

1(3.4%)

29Total

N/A(10)

Phase 4(7)

Phase 3(5)

Phase 1(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials

NCT04529148Phase 4Completed

The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression

Role: collaborator

NCT07724236Completed

A Retrospective Study on the Treatment of Stage II Kümmell's Disease With Cement-Augmented Short-Segment Internal Fixation (KD-CASSIF)

Role: lead

NCT07686796Phase 3Not Yet Recruiting

Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

Role: collaborator

NCT07337096Not ApplicableRecruiting

Electro-Acupuncture in Lung cancER : EALER Study

Role: collaborator

NCT07556224Recruiting

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

Role: collaborator

NCT07509775Recruiting

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Role: collaborator

NCT06461338Not ApplicableActive Not Recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

Role: collaborator

NCT07231523Phase 3Not Yet Recruiting

EFG vs IVIG in TAMG

Role: collaborator

NCT07139639Early Phase 1Not Yet Recruiting

Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease

Role: collaborator

NCT04694495Completed

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Role: collaborator

NCT06908473Phase 3Enrolling By Invitation

Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

Role: collaborator

NCT05339425Completed

Chinese Osteoporotic Fracture Registration Network Platform

Role: collaborator

NCT06743867Phase 1Recruiting

The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma

Role: collaborator

NCT06041477Phase 3Recruiting

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Role: collaborator

NCT06356675Phase 4Not Yet Recruiting

A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy

Role: lead

NCT03727230Not ApplicableCompleted

RhD+ Blood Transfusion to Asian-type DEL Recipients

Role: collaborator

NCT03616444Phase 2Completed

A Randomized Clinical Trial of Shenbai Granules in Reducing Recurrence of Colorectal Adenoma

Role: collaborator

NCT05769712Unknown

A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity

Role: collaborator

NCT05521282Phase 4Completed

The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension